Cowen And Company, LLC Iovance Biotherapeutics, Inc. Transaction History

Cowen And Company, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$16.55 - $27.63 $405,326 - $676,686	-24,491 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$20.35 - $26.63 $1.4 Million - $1.84 Million	-69,015 Reduced 73.81%	24,491 $604,000
Q1 2020 May 11, 2020	BUY	$19.54 - $38.85 $1.83 Million - $3.63 Million	93,506 New	93,506 $2.8 Million

343

247M

2.51M

3.5M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $590M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.